ɪn tˈuː θˈaʊzənd nˈaɪn, dʒˈɛnzaɪm ɐkwˈaɪɚd ðə ɹˈaɪts tə lˈuːkaɪn fɹʌm bˈeɪɚ, ɪŋklˈuːdɪŋ ðə mˌænjuːfˈæktʃɚɹɪŋ fəsˈɪlᵻɾi ɪnðə siːˈæɾəl ˈɛɹiə.
In 2009, Genzyme acquired the rights to Leukine from Bayer, including the manufacturing facility in the Seattle area.